Therapeutic approaches in metastatic renal cell carcinoma.
Staehler
Michael
M
Department of Urology, Klinikum Grosshadern, Ludwig Maximilians University Munich, Germany.
Rohrmann
Karl
K
Bachmann
Alexander
A
Zaak
Dirk
D
Stief
Christian G
CG
Siebels
Michael
M
D000315:Adrenalectomy / Q000379:methods; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000379:methods; D001859:Bone Neoplasms / Q000556:secondary; D019496:Cancer Vaccines / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000556:secondary* / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007680:Kidney Neoplasms; D009392:Nephrectomy / Q000379:methods; D013792:Thalidomide / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D019496:Cancer Vaccines; D013792:Thalidomide